Morning Guys22 Nov 2021 06:02
Monday 22nd November 2021, as the end of 2021 approaches, first patients have been dosed in Covidity trial, and now the SCIB1/KEYTRUDA trial, and at least we know the data from big trials is underway. Updates on MOD1, MABS AND ADVIDAMAB ARE DUE, as is news on all proprietry platforms. I would like nothing more than aother RNS before AGM To close a year in which our share price rerated, I took some nice profits and come into 2022 with a core holding of 200k.
Hoping to get to the AGM tomorrow but spending today at UCLH for my 3 monthly scans and consultant appointment, dependant on that hope to have the energy and will to attend.
So good luck all for whatever occurs this week, we seem to be shaping well for 2022, let hope it is a great one.....ATB